AVERSA, Franco
 Distribuzione geografica
Continente #
NA - Nord America 9.685
AS - Asia 6.665
EU - Europa 6.277
SA - Sud America 807
AF - Africa 84
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 3
Totale 23.543
Nazione #
US - Stati Uniti d'America 9.426
CN - Cina 2.833
SG - Singapore 2.035
IE - Irlanda 1.487
FI - Finlandia 899
SE - Svezia 894
HK - Hong Kong 873
IT - Italia 834
DE - Germania 751
BR - Brasile 731
TR - Turchia 669
UA - Ucraina 415
NL - Olanda 389
CA - Canada 218
RU - Federazione Russa 161
FR - Francia 105
GB - Regno Unito 99
AT - Austria 65
IN - India 60
BE - Belgio 43
BD - Bangladesh 41
VN - Vietnam 33
AR - Argentina 30
CI - Costa d'Avorio 29
PL - Polonia 28
CZ - Repubblica Ceca 23
EU - Europa 22
MX - Messico 20
ZA - Sudafrica 20
RO - Romania 19
ES - Italia 17
VE - Venezuela 15
IQ - Iraq 14
JP - Giappone 14
LT - Lituania 13
EC - Ecuador 12
SA - Arabia Saudita 11
UZ - Uzbekistan 10
PK - Pakistan 9
JO - Giordania 7
CO - Colombia 6
TW - Taiwan 6
DZ - Algeria 5
IR - Iran 5
NP - Nepal 5
PY - Paraguay 5
BO - Bolivia 4
EG - Egitto 4
ID - Indonesia 4
IL - Israele 4
JM - Giamaica 4
KG - Kirghizistan 4
KH - Cambogia 4
MA - Marocco 4
PA - Panama 4
PT - Portogallo 4
SI - Slovenia 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
AO - Angola 3
BG - Bulgaria 3
BY - Bielorussia 3
CH - Svizzera 3
CM - Camerun 3
CR - Costa Rica 3
GA - Gabon 3
GR - Grecia 3
KE - Kenya 3
QA - Qatar 3
RS - Serbia 3
AU - Australia 2
BN - Brunei Darussalam 2
CL - Cile 2
DK - Danimarca 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
LU - Lussemburgo 2
NG - Nigeria 2
NI - Nicaragua 2
OM - Oman 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
SN - Senegal 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BS - Bahamas 1
CG - Congo 1
CY - Cipro 1
EE - Estonia 1
HR - Croazia 1
HU - Ungheria 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
Totale 23.537
Città #
Dublin 1.487
Chandler 1.468
Singapore 1.106
Jacksonville 905
Hong Kong 866
Beijing 846
Ashburn 762
Izmir 622
Nanjing 478
Santa Clara 460
Boardman 415
Dearborn 382
Princeton 352
San Mateo 330
Parma 301
Ann Arbor 236
Wilmington 235
Columbus 234
Toronto 172
New York 168
Helsinki 154
Shenyang 153
Kunming 144
Nanchang 141
Moscow 135
Shanghai 135
The Dalles 133
Hebei 115
Council Bluffs 110
Jinan 97
Munich 97
Des Moines 92
Hefei 83
Jiaxing 79
Tianjin 78
Changsha 74
Los Angeles 64
Düsseldorf 59
Vienna 53
Guangzhou 46
Norwalk 46
São Paulo 45
Turku 42
Milan 40
Seattle 38
Brussels 36
Bologna 34
Hangzhou 32
San Francisco 32
Dallas 31
Frankfurt am Main 29
Kocaeli 29
Zhengzhou 29
Abidjan 28
Woodbridge 28
Marseille 27
Chengdu 26
Rome 26
Falls Church 24
Bremen 23
Belo Horizonte 21
Mestre 21
Fremont 20
Rio de Janeiro 20
Boston 19
Chicago 19
Haikou 19
London 19
Brasília 15
Brno 15
Focsani 15
Houston 15
Porto Alegre 15
Warsaw 15
Wuhan 14
Borås 13
Ningbo 13
Ottawa 13
Frankfurt Am Main 12
Fuzhou 12
Nuremberg 12
Brooklyn 11
Campinas 11
Chongqing 11
Grafing 11
Guarulhos 11
Pune 11
Redmond 11
Taizhou 11
Carpi 10
Chennai 10
Hanoi 10
Modena 10
Radomsko 10
Tashkent 10
Curitiba 9
Johannesburg 9
Osasco 9
Philadelphia 9
Phoenix 9
Totale 15.042
Nome #
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 159
Sindrome preleucemica 148
The -2518 A/G polymorphism of the monocyte chemoattractant protein-1 as a candidate genetic predisposition factor for secondary myelofibrosis and biomarker of disease severity 147
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC 138
Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20 137
The Proteasome and Myeloma-Associated Bone Disease 136
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target 136
Ammonium Production and Glutamine-Addiction of Myeloma Cells: New Attractive Targets in Multiple Myeloma 135
Neurofibromatosis type I and multiple myeloma coexistence: A possible link? 134
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors 125
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 120
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 119
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation 119
The -2518 A/G single nucleotide polymorphism of MCP-1 in myelofibrosis: functional characterization on ex-vivo patient cells. 118
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 117
Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma 116
A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading Diagnosis 116
Addition of Bortezomib to High Dose Melphalan As Conditioning Regimen for Autologous Stem Cell Transplantation Improves the Response Rate in Newly Diagnosed Multiple Myeloma Patients 112
Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells 110
Protein kinase Cɛ inhibition restores megakaryocytic differentiation of hematopoietic progenitors from primary myelofibrosis patients 110
Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients. 108
''Designed'' grafts for HLA-haploidentical stem cell transplantation 108
Bone Marrow DKK-1 Levels in Smoldering Multiple Myeloma Patients: A New Independent Risk Factor for Progression 107
Bone Marrow Remodelling and Topographic Redistribution of CD34 Positive Progenitors Characterize the Progression of Myelodysplastic Syndromes and Their Evolution to AML 107
Hypoxia-Inducible Factor (HIF)-1 alpha Inhibitionin Myeloma Cells Significantly Increases the Anti-Myeloma Effect of Lenalidomide in Vivo 106
LENALIDOMIDE INCREASES HUMAN DENDRITIC CELL MATURATION MODULATING BOTH MONOCYTE DIFFERENTIATION AND MESENCHYMAL STROMAL CELL INHIBITORY PROPERTIES 106
The osteoblastic niche in the context of multiple myeloma 105
Bortezomib improves bone integrity in multiple myeloma patients by blocking osteocyte death and autophagy 104
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 103
GOOD IMMUNOLOGICAL RECONSTITUTION IN ADULTS WITH ACUTE LEUKEMIA AFTER.LFA-BETA TCR/CD19+DEPLETED HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) 102
EXPRESSION OF CD38 AND ECTOENZYMES OF THE ADENOSINERGIC PATHWAYS IN MYELOMA BONE NICHE: A RATIONAL BASIS FOR THE USE OF DARATUMUMAB TO TARGET OSTEOCLAST FORMATION IN MULTIPLE MYELOMA 101
[Evaluation of the immunological status of patients with Hodgkin's disease] 100
Primary Prophylaxis of Invasive Fungal Diseases in Allogeneic Stem Cell Transplantation: Revised Recommendations from a Consensus Process by Gruppo Italiano Trapianto Midollo Osseo (GITMO) 100
Serie granulocitaria 99
The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells 99
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties 99
PROTEIN KINASE Ce EXPRESSION IN PRIMARY MYELOFIBROSIS PLATELETS CORRELATES WITH CARDIOVASCULAR EVENTS 99
DEPENDENCE ON GLUTAMINE UPTAKE OF MYELOMA CELLS DELINEATES A NEW ATTRACTIVE THERAPEUTIC STRATEGY 98
PCM1-JAK2 Fusion Product Selectively Activates MAP-Kinase Pathway and Fails to Phosphorylate JAK2 and STAT5: Implications for Therapeutic Strategies. 97
Platelet expression of PKCepsilon oncoprotein in myelofibrosis is associated with disease severity and thrombotic risk 97
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. 96
Bone marrow CD14+ cells show different transcriptional profiles in Multiple Myeloma (MM) as compared to smoldering MM and MGUS: overexpression of IL21R and its involvement in osteoclastogenesis 96
[Sequential polychemotherapeutic treatment of inoperable bronchogenic carcinoma] 96
Microbiota control of a tryptophan–AhR pathway in disease tolerance to fungi 96
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia. 95
ERK1/2 is the signaling pathway primarily activated in myeloid neoplasms carrying t(8;9)/PCM1-JAK2 fusion. A two cases report. 95
The anti-myeloma effect of Lenalidomide is increased by hypoxia-inducible factor (HIF)-1a inhibition in multiple myeloma cells both in vitro and in vivo 93
Galectin-1 Is Highly Expressed By Myeloma Cells and the Bone Marrow Microenvironment and Its Suppression Delineates a New Therapeutic in Vitro and in Vivo Strategy in Multiple Myeloma 93
IN VITRO CHARACTERISTICS OF HEMATOPOIETIC PROGENITORS FROM PRIMARY MYELOFIBROSIS PATIENTS CORRELATE WITH IPSS/DIPSS RISK CATEGORY 93
Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo 93
Expression Profile of CD38 and Related Ectoenzymes in Myeloma Bone Niche: A Rational Basis for the Use of Daratumumab to Inhibit Osteoclast Formation and Activity 93
Amiloidosi 92
Haploidentical stem cell transplantation after negative depletion of T cells expressing the alfabeta chain of the T-cell receptor (TRC) for adults with haematological malignamcies 92
TLR3 essentially promotes protective class I-restricted memory CD8⁺ T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. 92
T cell depleted haploidentical transplantation: positive selection. 91
A prospective, multicentre survey on antifungal therapy in neutropenic paediatric haematology patients. 91
Acute lymphoblastic leukaemia in Noonan syndrome. 90
Acquisition of Ig isotype diversity after bone marrow transplantation in adults. A recapitulation of normal B cell ontogeny. 89
Norfloxacin prophylaxis for neutropenic patients undergoing bone marrow transplantation. 89
The haploidentical option for high-risk haematological malignancies. 89
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria 89
Etiology of febrile episodes in patients with acute myeloid leukemia: results from the Hema e-Chart Registry 88
Favorable clinical outcome and response to immunotherapy share a common PD-L1/PD-1 based NSCLC immune contexture 88
Protein Kinase C Epsilon Inhibition Restores In-Vitro Megakaryocyte Differentiation Of Primary Myelofibrosis Hematopoietic Progenitors 88
T Cell Responses in Fungal Infections 87
Oncolytic Virotherapy in Multiple Myeloma: A Possible Alternative Role of Bovine Viruses 87
Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamide 87
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 87
Allogeneic Hematopoietic stem cell transplantation and natural killer cell alloreactivity, 85
Epidemiology of Fungal Infections In Hematological Sem Cells Transplanted Patients: SEIFEM 2004 Study 84
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. 84
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 84
Proteasome Inhibitors Block Myeloma-Induced Osteocyte Death in Vitro and in Vivo in Multiple Myeloma Patients 84
Mieloma multioplo ed altre discrasie linfoplasmacellulari 83
Hema e-Chart: Italian Registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies. 83
Germline PTPN11 mutation affecting exon 8 in a case of syndromic juvenile myelomonocytic leukemia 83
T cell depleted HLA-identical bone marrow transplants 83
A prospective survey of febrile events in hematological malignancies 83
Genetic PTX3 Deficiency and Aspergillosis in Stem-Cell Transplantation 82
Non-B, non-T acute lymphoblastic leukaemia terminating in malignant histiocytosis: a new case and a review of the literature. 82
Trascriptome Analysis of Bone Marrow CD14+ Monocytes Revealed Differential Expression Profiles in Symptomatic Multiple Myeloma (MM) Compared to Smoldering MM and Monoclonal Gammopathy of Undetermined Significance 82
Hypoxia-inducible factor (HIF)-1 is a therapeutic target in myeloma-induced angiogenesis and bone destruction in vitro and in vivo 82
Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation. 81
Allogeneic transplants of rhG-CSF-mobilized peripheral blood stem cells (PBSC) from normal donors. GITMO. Gruppo Italiano Trapianto di Midollo Osseo. 81
Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin? 81
Therapeutic Strategy for Elderly Patients with ACUTE Myeloid Leukemia (AML) Carrying the DNMT3A Mutation 81
Provision of antifungal immunity and concomitant alloantigen tolerization by conditioned dendritic cells in experimental hematopoietic transplantation. 81
Allogeneic stem cell transplantation compared with chemotherapy for poor-risk Hodgkin lymphoma. 80
The link between bone microenvironment and immune cells in multiple myeloma: Emerging role of CD38 80
BORTEZOMIB WITH HIGH DOSE MELPHALAN CONDITIONING FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IS SAFE AND IMPROVES THE RESPONSE RATE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA 80
Lenalidomide Increases Human Dendritic Cell Maturation in Multiple Myeloma Modulating Both Monocyte Differentiation and Mesenchymal Stromal Cell Inhibitory Properties through Ikaros and Casein Kinase 1 Degradation, Respectively 80
T-cell depletion in allogeneic bone marrow transplantation for acute leukaemias. 79
Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. 79
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project 78
Relationship between bone imaging features and bone marrow cytokine and chemokine profiles in patients with monoclonal gammopathy 78
Bone marrow monocyte-/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myeloma 78
Is histiocytic reticulosis an infectious disease? 77
Lung damage following bone marrow transplantation after hyperfractionated total body irradiation. 77
A multidrug-resistant Pseudomonas aeruginosa isolate from a lethal case of sepsis induces necrosis of human neutrophils. 77
Human thrombopoiesis depends on PKCdelta/PKCepsilon functional couple 77
Totale 9.741
Categoria #
all - tutte 93.577
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.577


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.388 19 206 39 31 271 25 27 19 438 46 244 23
2021/20221.512 19 15 17 64 45 28 170 257 62 197 85 553
2022/20235.299 688 350 244 381 463 586 60 352 1.913 35 165 62
2023/20241.800 128 230 53 60 155 515 68 116 25 68 144 238
2024/20256.419 62 398 520 413 640 424 182 367 838 627 605 1.343
2025/2026659 659 0 0 0 0 0 0 0 0 0 0 0
Totale 23.847